Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-17

FDA Approved: RIFABUTIN — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved rifabutin under an original application for ANI Pharmaceuticals, Inc. (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RIFABUTIN (Rifabutin)

Snippet

ORIG AP for RIFABUTIN (RIFABUTIN)